JENNIFER BRESEMAN: Open Payments
NPI 1205461498 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 7 payments from 6 companies in 2025. Trend: 2023 $229 · 2024 $314 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Astellas Pharma US Inc | 1 | $95 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| Cranial Technologies, Inc | 2 | $41 |
Products named: DUPIXENT, ZENPEP, Auvelity, Veozah, SPRAVATO, Doc Band.
Industry payments across VA — which companies pay providers there.
